AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effects of Mobilization and Caffeine After Cesarean

RecruitingNAAges 18 Years - 35 YearsFemaleKTO Karatay University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study Maims to assess bowel motility, pain and psychological well-being in women in the post-cesarean period by mobilizing them early and encouraging them to consume coffee.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Being between 18 and 35 years of age, 2. Women who underwent cesarean delivery under spinal anesthesia, 3. Having a post-cesarean pain level of 4 or higher, 4. Being able to understand and write Turkish and communicate effectively with researchers. Exclusion Criteria: 1. Women who underwent emergency cesarean delivery, 2. Those with pregnancy complications (preeclampsia, placenta previa, etc.), 3. Those with a history of chronic gastrointestinal disease (e.g., irritable bowel syndrome, Crohn's disease, ulcerative colitis), 4. Those with sensitivity or allergy to caffeine, 5. Those with a history of chronic pain syndrome or dependence on analgesics, 6. Regular coffee drinkers (โ‰ฅ2 cups per day), 7. Intraoperative complications such as bowel or bladder injury, i) Those who cannot comply with the study protocol or complete the follow-up process. Removal Criteria: 1. Participants are excluded from the study under the following conditions: 2. During surgery If complications occur (e.g., bladder or bowel injury, excessive bleeding), 3. Postoperative complications requiring admission to the intensive care unit (ICU) for the mother or newborn, 4. Development of severe postoperative nausea, vomiting, or intolerance to oral intake, 5. Inability to consume or refusal to consume coffee according to the study protocol, 6. Withdrawal of consent by the participant at any point during the study, 7. Failure to comply with surgical procedures or loss of follow-up, 8. Development of medical conditions during follow-up that may affect study results (e.g., acute infections, neurological disorders).
๐Ÿ’Š

What it tests

  • caffeine consumption
  • Decaffeinated coffee
๐Ÿ“

Where

1 site
KTO Karatay University
Konya, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy